MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial

Florentine E. F. Timmer, Bart Geboers, Alette H. Ruarus, Laurien G. P. H. Vroomen, Evelien A. C. Schouten, Susan van der Lei, Danielle J. W. Vos, Madelon Dijkstra, Hannah H. Schulz, Joyce Bakker, Bente A. T. van den Bemd, M. Petrousjka van den Tol, Robbert S. Puijk, Birgit I. Lissenberg‐Witte, Tanja D. de Gruijl, Jan J.J. de Vries, Frank J. Lagerwaard, Hester J. Scheffer, A. Bruynzeel, Martijn R. Meijerink